Company profile: Sware
1.1 - Company Overview
Company description
- Provider of a validation automation platform and managed services for life sciences. Res_Q automates and unifies GxP validation to reduce validation time and ensure audit readiness. Managed Services Programs support implementation and management of Res_Q, including training and ongoing compliance assistance. Industry Accelerators via Sware's Marketplace offer over 30 integrated applications to expedite implementation and automate compliance.
Products and services
- Res_Q: A GxP-centric validation automation platform engineered for life sciences, automating and unifying validation processes to reduce validation time and ensure audit readiness
- Industry Accelerators: Marketplace-integrated applications—over 30 integrated components—expedite implementation and automate compliance processes, supported by Sware’s Marketplace to streamline deployment and compliance automation
- Managed Services Programs: Compliance-focused programs deliver support for implementing and managing Res_Q, including training and ongoing compliance assistance
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Sware
Jumpcode Genomics
HQ: United States
Website
- Description: Provider of CRISPR-mediated rRNA and DNA depletion kits for sequencing workflows, improving sensitivity and performance. Solutions include single-cell RNA boost kits (CRISPRclean, DepleteX) to remove uninformative transcripts and undesired fragments; bulk RNA/DNA depletion for stranded RNA-Seq; mitochondrial DNA, nasopharyngeal RNA, and human DNA depletion to enhance genomic and microbial analyses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jumpcode Genomics company profile →
Protein Forest
HQ: United States
Website
- Description: Provider of instruments, consumables, and software for protein separation and bioanalysis, serving scientists in the United States and internationally. Offers the digital ProteomeChip (dPC), which fractionates and concentrates proteins or peptides by isoelectric focusing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Protein Forest company profile →
Gene Logic
HQ: United States
Website
- Description: Provider of comprehensive Genomic Reference Databases and GLP-compliant Microarray Services as part of an integrated genomics offering, serving over two-thirds of the top 25 pharma companies, leading research institutes, and emerging biotech companies worldwide.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Gene Logic company profile →
GoBalto
HQ: United States
Website
- Description: Provider of cloud-based solutions for drug trial sponsors and clinical research organizations to simplify and accelerate clinical studies on the web. Offerings include tools for selecting, activating and analyzing clinical trial sites; a unified platform integrating people, processes and data; and safety case and signal management solutions supporting pharmacovigilance and regulatory compliance.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full GoBalto company profile →
Vividion Therapeutics
HQ: United States
Website
- Description: Provider of a proteome-wide chemoproteomic platform for drug and target discovery and small-molecule therapeutics in oncology and immunology, including programs for NRF2 inhibition in squamous lung, head, neck and esophageal cancers; NRF2 activation for inflammation-induced tissue injury; STAT3 targeting (incl. oral investigational VVD-130850 for advanced solid and hematologic tumors); and Werner helicase targeting for microsatellite instability cancers.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vividion Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Sware
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Sware
2.2 - Growth funds investing in similar companies to Sware
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Sware
4.2 - Public trading comparable groups for Sware
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →